Healthcare Asia on MSN1 小时
Chronic obstructive pulmonary disease market to hit $30.8b by 2033
Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...
EURACTIV10 小时
Improving COPD patients’ lives needs better diagnosis, drugs, devices
Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...
pulmonologyadvisor14 小时
Using SGLT2i in COPD With Diabetes Linked to Fewer Hospitalizations, ED Visits
Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.
FDA's promised guidance on pulse oximeters unlikely to end decades of racial bias, say experts
The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well ...
First of its Kind Medicine Approved for A Chronic Lung Disease
In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...
Medscape17 小时
AF Burden Increases Around Time of COPD Hospitalizations
In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...
healthday18 小时
Older People More Prone to Relocating After Dementia Diagnosis
A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows.“O ...
Janesville Gazette21 小时
FDA’s promised guidance on pulse oximeters unlikely to end decades of racial bias
The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well above the 88% blood oxygen saturation level ...